|
Volumn 43, Issue 2, 2011, Pages 466-468
|
Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN INHIBITOR;
MYCOPHENOLIC ACID;
PREDNISONE;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GERIATRIC PATIENT;
GLOMERULUS FILTRATION RATE;
GRAFT SURVIVAL;
HERPES ZOSTER;
HIGH RISK POPULATION;
HOSPITAL READMISSION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LOW DRUG DOSE;
MALE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TREATMENT OUTCOME;
VIRUS INFECTION;
AGE FACTORS;
AGED;
ANIMALS;
ANTILYMPHOCYTE SERUM;
BACTERIAL INFECTIONS;
CALCINEURIN;
CASE-CONTROL STUDIES;
FEMALE;
GLOMERULAR FILTRATION RATE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
PATIENT READMISSION;
PREDNISONE;
RABBITS;
RANDOM ALLOCATION;
RETROSPECTIVE STUDIES;
|
EID: 79953193081
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.01.039 Document Type: Conference Paper |
Times cited : (24)
|
References (12)
|